Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic, the brand-name form of semaglutide, has become one of the most widely prescribed medications for weight management since its approval by the FDA for weight loss in 2021. Clinical research demonstrates that people taking semaglutide lose significantly more weight than those on diet and exercise alone. Understanding how this medication works, what the evidence shows, and what options are available can help you make an informed decision about whether GLP-1 therapy is right for your health goals.

How Semaglutide Produces Weight Loss Results

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which mimic a natural hormone your body produces to regulate blood sugar and appetite. When you take semaglutide, it slows how quickly your stomach empties, increases feelings of fullness, and signals your brain that you need less food to feel satisfied. This three-part mechanism addresses weight gain at its source rather than simply restricting calories through willpower alone.

The medication also improves how your body metabolizes glucose and can reduce cravings for high-calorie foods. Many patients report that foods they once craved no longer appeal to them at the same intensity. This shift in appetite and food preferences, combined with sustained feelings of satiety, creates conditions where weight loss becomes more sustainable and requires less constant mental effort.

Clinical Evidence: Weight Loss Success Rates

The landmark STEP trials, which tested semaglutide in people with obesity, found that participants lost an average of 15-22% of their body weight over 68 weeks—compared to only 2-3% in the placebo group. In the highest-dose group, nearly 50% of participants achieved 20% or greater weight loss, a threshold that translates to meaningful improvements in blood pressure, cholesterol, and joint function. These results represent one of the most significant pharmaceutical interventions for weight management documented in modern medicine.

Long-term follow-up data shows that weight loss is generally maintained as long as the medication is continued, though some weight may return if treatment stops. The consistency of these results across different age groups, body types, and baseline health conditions suggests that semaglutide's effectiveness is robust and predictable for most users. Success rates remain high even in people who have struggled with weight loss for decades.

Compounded Semaglutide vs. Brand-Name Ozempic

Brand-name Ozempic can cost $1,000 or more per month, even with insurance, placing it out of reach for many patients who would benefit from treatment. PlexusDx offers compounded semaglutide injections starting at $149 per month, prepared by licensed 503A compounding pharmacies and available to all 50 states without requiring insurance. Compounded semaglutide uses the same active pharmaceutical ingredient as the brand name, delivered through identical injection mechanisms, with the primary difference being cost and accessibility.

The FDA does not approve individual compounded medications the way it approves brand-name drugs, but 503A compounding pharmacies operate under strict federal and state regulations that ensure sterility, potency, and safety. PlexusDx's compounding partners maintain these rigorous standards while eliminating the markup that makes brand-name medications expensive. Many patients find that compounded semaglutide delivers the same clinical outcomes as Ozempic at a fraction of the price.

Side Effects and What to Expect

The most common side effects of semaglutide are gastrointestinal in nature: nausea, vomiting, diarrhea, and constipation. These effects tend to be mild to moderate, decrease over time as your body adjusts, and often improve when doses are increased gradually rather than all at once. Most people report that side effects are manageable and resolve within 2-4 weeks, especially when started at lower doses. Serious side effects are rare, and the medication has a favorable safety profile in clinical trials.

Some patients experience temporary appetite suppression that goes beyond what is therapeutic, requiring dose adjustment downward. Others develop a preference for smaller portions that persists even when side effects subside. It is important to work with a healthcare provider who can monitor your response, adjust your dose if needed, and help distinguish between helpful appetite regulation and problematic loss of appetite. PlexusDx provides personalized medication protocols designed to optimize both efficacy and tolerability.

Personalization: Genetic Testing for GLP-1 Response

Not every person responds identically to semaglutide, and genetic variation plays a significant role in how well the medication works for you. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month), which analyzes 14 metabolic pathways and 150+ genetic insights related to peptide signaling and weight regulation. Key variants in the GLP1R and GIPR genes directly influence how your body responds to GLP-1 medications, while mutations in FTO and MC4R affect baseline hunger signals and energy expenditure.

By mapping your genetic predispositions before starting treatment, PlexusDx can recommend the specific GLP-1 compound—semaglutide, tirzepatide, microdose protocols, or dual combinations—most likely to work best for your biology. This precision-medicine approach reduces trial-and-error dosing, accelerates your path to effective weight loss, and improves your likelihood of reaching your goals. Genetic testing transforms weight loss from a one-size-fits-all approach into a personalized strategy aligned with your unique physiology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically lose on semaglutide?

Clinical trials show average weight loss of 15-22% of body weight over approximately 4 months of treatment. Some patients lose more, and results depend on your starting weight, adherence to the medication protocol, and lifestyle factors. PlexusDx patients often report substantial improvements in energy, mobility, and metabolic markers alongside weight loss.

How does semaglutide compare to other weight loss medications?

Semaglutide is one of the most effective medications available for weight loss, with stronger clinical evidence than older options like phentermine. Tirzepatide, another medication PlexusDx offers, targets two receptors (GLP-1 and GIP) and produces slightly higher average weight loss in some studies. Your ideal choice depends on your genetic profile, medical history, and personal response to the medication.

Is compounded semaglutide as effective as brand-name Ozempic?

Yes, compounded semaglutide contains the identical active ingredient and delivers the same clinical results. The difference is that PlexusDx sources from licensed 503A compounding pharmacies and passes savings to you—starting at just $149 per month with no insurance required. Your dose may need to go up. Your price won't.

Are there serious risks or contraindications with semaglutide?

Semaglutide is contraindicated in people with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome. Most side effects are gastrointestinal and mild. Serious adverse events are rare in clinical trials, and the medication has been used safely in millions of patients. Your PlexusDx provider will review your medical history to ensure semaglutide is appropriate for you.

How can genetic testing help me choose between semaglutide and other GLP-1 options?

PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that predict your response to different GLP-1 compounds. If your genetic profile shows strong GLP1R signaling potential, semaglutide may be ideal. If GIP-pathway variants are dominant, tirzepatide or PlexusDx's dual-compound options may deliver better results. Testing removes guesswork and accelerates your path to weight loss success.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves